New York City, NY -- (SBWIRE) -- 10/30/2013 -- StockMarketIntel.com issues a special report on the following stocks: Excel Maritime Carriers Ltd (OTCMKTS:EXMCQ), Mallinckrodt PLC (NYSE:MNK), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Urban Ag Corp (OTCMKTS:AQUM)
Excel Maritime Carriers Ltd (OTCMKTS:EXMCQ) trading on 527,603 shares, to end the trade at $0.260. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.03 and was moved to the maximum level of $1.30. The stock changed hands in a range of $0.25 to $0.27, bringing its market capitalization to about $24.24 million. Excel Maritime Carriers Ltd. (Excel) is engaged in providing worldwide sea borne transportation services for drybulk cargo including, among others, iron ore, coal and grain, collectively referred to as major bulks, and steel products, fertilizers, cement, bauxite, sugar and scrap metal, collectively referred to as minor bulks. As of December 31, 2011, the Company owned a fleet of 40 vessels (including one vessel owned through a joint venture in which the Company held a 71.4% interest) and, together with seven vessels under bareboat charters, operated a fleet of 47 vessels (seven Capesize, 14 Kamsarmax, 21 Panamax, two Supramax and three Handymax vessels) with a total carrying capacity of approximately 4.1 million deadweight.
Should EXMCQ a Buy or Sell Now Find Out Here
Mallinckrodt PLC (NYSE:MNK) declined -0.71%, to complete the trading session at $43.06, with a total volume of 269,007 shares. The stock, on average, trades on a volume of 733,294shares. In the past 52 weeks, the share price has not declined below $41.00 and above $50.00. It floated in a range of $42.72 to $43.47. Its market capitalization now moved to about $248.44million. Mallinckrodt public limited company (Mallinckrodt) is a global specialty pharmaceuticals company. The Company develops, manufactures, markets and distributes both branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API) and diagnostic imaging agents.
Is it the Right to Grab MNK after the Recent Slump? Get Free Trend Analysis Here
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) recorded a gain of 3.00% and was in a range of $59.15-$61.53 before closing at $61.49. The share price hit its 52-week low of $14.88 and $66.17 was the best price. The stock completed the day with a total volume of 425,088 shares, versus an average volume of 860,477 shares. Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). Its Alnylam 5x15, is focused on the development and commercialization of novel RNAi therapeutics for the treatment of genetically defined diseases.
Will ALNY Continue To Move Higher? Find Out Here
Urban Ag Corp (OTCMKTS:AQUM) declined -7.69% yesterday, bringing its market capitalization around $57,684. The total number of shares that changed hands during the session was 77.36 million shares, as compared to average trading volume of 66.41 million shares. The share price, after opening at $0.0013, made a high of $0.0013 and hovered above $0.0011 to end the day at $0.0012. Urban Ag. Corp., formerly Aquamer, Medical Corp, is a clinical development-stage company. It focuses on providing invasive injectable modalities for dermatology, urology, gastroenterology and orthopedic surgery. The bulking agent that comprises its initial products involves the use of a polymeric component from the poly-n-vinyl pyrrolidinone (PVP) family, which is recognized for its biocompatibility and clinical use. PVP is a non-toxic, non-metabolized hydrogel that approved for use as a plasma volume expander, plasma detoxifying agent, an orally-ingested diagnostic aid,component of soft contact lenses, a variety of dental applications, a filler for a permanent implantable urological device and as an excipient in the manufacturing of tablets containing a variety of drugs.
Will AQUM Reach the Bottom after Yesterday’s Correction? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)